MetLife Investment Management, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$521,649
+94.9%
14,0910.0%0.00%
+100.0%
Q2 2022$267,588
-29.6%
14,0910.0%0.00%
-33.3%
Q1 2022$380,316
+149.9%
14,091
+108.6%
0.00%
+200.0%
Q4 2021$152,168
-14.0%
6,7540.0%0.00%
-50.0%
Q3 2021$177,022
-18.1%
6,7540.0%0.00%0.0%
Q2 2021$216,196
-9.1%
6,7540.0%0.00%0.0%
Q1 2021$237,808
+9.8%
6,7540.0%0.00%0.0%
Q4 2020$216,601
-14.8%
6,7540.0%0.00%
-33.3%
Q3 2020$254,085
-15.9%
6,7540.0%0.00%0.0%
Q2 2020$302,2426,7540.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders